HOVON HO60
Archived
Main info
- Identifier:
- HOVON 60 MDS SAKK 3399
- Sponsor:
- HOVON
- Included patients:
-
88
- Active sites:
-
4(of 3)
- Title:
Antithymocyte globulin (ATG) and cyclosporine (CSA) in high risk myelodysplastic syndrome (MDS): a randomized trial comparing ATG + CSA with best supportive care.
Timeline
Scheduled
Actual
2015
13 Oct
Archived
2030
13 Oct
Destruction
Flow
Details
- Phase:
- Prospective randomized Phase III study
- Monitoring Type:
- Objectives:
Eligibility
- Inclusion Criteria:
- Documented MDS
- Patients in any of the following groups:
a. Hypoplastic MDS
b. MDS subtype RA (refractory anemia)
c. MDS subtype RAS (refractory anemia with sideroblasts)
d. MDS subtype RAEB (refractory anemia with excess of blasts) with 10-20% blasts in bone marrow and patient unwilling or not eligible to participate in the HOVON 42 or 43 study- Transfusion dependence of less than 24 months duration, defined as any of the following conditions:
a. Packed red cells transfusion > 2 units per month for a period of >= 2 months
b. Untransfused hemoglobin level <= 8 g/dl
c. Platelet transfusion > 1 unit per 2 weeks for a period of > 1 month
d. Untransfused platelet count <= 20x10^9/l
e. Neutrophils < 0.5x109/l- Age > 18 years
- ECOG/SAKK performance status <= 2
- Written informed consent
- Exclusion Criteria:
- MDS types CMMoL (chronic myelo-monocytic leukemia), RAEBt (refractory anemia with excess blasts in transformation)
- Patients scheduled for bone marrow transplant
- History of other hemato-oncological disease except for non melanoma skin cancer and adequately treated in situ carcinoma of the cervix
- Prior chemotherapy or radiotherapy
- Serum creatinine or bilirubin > 2.5 x upper limit of normal
- History of heart failure, or clinically relevant cardiac arrhythmia
- History of allergy to horse proteins, anaphylactic reactions to animal proteins, or history of serum sickness
- Female patients with stablished pregnancy, or of childbearing age not practicing adequate contraceptive
- Positive HIV serology
- Active chronic hepatitis B or C
- Active uncontrolled infection
Participating Sites
Site
3 results
Order by
Accrual rate
Activation date
NL-Enschede-MST
3
NL-Amsterdam-VUMC
3
NL-Nieuwegein-ANTONIUS
= Active hospitals
= Inactive hospitals